Scientists uncover new targets for treating Parkinson’s disease
LA JOLLA, CA—Scientists at La Jolla Institute for Immunology (LJI) have found that people with Parkinson’s disease have a clear
LA JOLLA, CA—Scientists at La Jolla Institute for Immunology (LJI) have found that people with Parkinson’s disease have a clear
The aim of this work funded by Aligning Science Across Parkinson’s (ASAP), in collaboration with Dr. Alessandro Sette, is to
The aim of this work, in collaboration with Dr. Bjoern Peters, is to identify and characterize T cell epitopes from
LA JOLLA—A long, long time ago, the BCG vaccine was approved for use against tuberculosis (TB), and it’s still
Researchers tracking COVID-19 mortality early in the pandemic noticed that some countries had a significantly lower mortality rate than others.
LA JOLLA—Scientists at the La Jolla Institute for Immunology (LJI) have received $3.5 million as part of a team award
LA JOLLA—A new study co-led by scientists at the La Jolla Institute for Immunology (LJI) adds increasing evidence that Parkinson’s